|
dataset contains multiple samples per subject, but these cannot be linked with the available metadata
|
2934 |
|
additional metadata available upon request (see paper)
|
924 |
|
The stated sample location differs between the paper and the uploaded metadata. Coordinates follow the paper.
|
400 |
|
no antibiotic treatment 2 months before sampling
|
368 |
|
exact timepoint unknown
|
305 |
|
gestational age and age in days do not always match
|
293 |
|
due to incomplete metadata, is is not possible to identify subjects, timepoints, BMI and intervention
|
152 |
|
age range: 10th to 90th percentile
|
149 |
|
allogeneic haematopoietic stem-cell transplant recipient
|
136 |
|
subject identifiers are unknown
|
128 |
|
related paper: https://doi.org/10.1371/journal.pntd.0008783
|
96 |
|
Donor samples are mixtures of stool from two donors
|
93 |
|
no antibiotics 60d prior to FMT; no probiotics 30d prior; steroids tapered for at least 14d prior to FMT
|
49 |
|
500 mg twice daily for five days
|
43 |
|
FMT donor
|
41 |
|
mapping between deposited sequences and metadata needed to be manually inferred by Sebastian Schmidt
|
41 |
|
each subject provided duplicate fecal samples
|
30 |
|
subject took no medication and had no allergies
|
30 |
|
most patients received antibiotics
|
26 |
|
treatment metadata is unclear
|
25 |
|
inconsistent metadata on sex and birth weight given
|
22 |
|
FMT donor 2 sample
|
18 |
|
pre thoracic aortic dissection operation
|
14 |
|
FMT donor 1 sample
|
11 |
|
SAMEA104393740 is mislabelled: it clusters with the donor samples instead of the recipients; experiment has been removed from the db
|
11 |
|
second antibiotic taken Cotrimoxazole
|
9 |
|
post thoracic aortic dissection operation
|
8 |
|
Sample taken after overnight fasting and ingestion of 10^8 colonoy-forming units of Escherichia coli
|
7 |
|
Subject also on vancomycin
|
7 |
|
Subjects Langdon_2021_RCDI.subject_A24.1 and Langdon_2021_RCDI.subject_A24.2 are the same person, but relative timing is unclear
|
7 |
|
Subjects Langdon_2021_RCDI.subject_A7.1 and Langdon_2021_RCDI.subject_A7.2 are the same person, but relative timing is unclear
|
7 |
|
FMT donor was unrelated
|
6 |
|
Subject also on vancomycin, fidaxomycin
|
6 |
|
Subjects Langdon_2021_RCDI.subject_A10.1 and Langdon_2021_RCDI.subject_A10.2 are the same person, but relative timing is unclear
|
6 |
|
Subjects Langdon_2021_RCDI.subject_A17.1 and Langdon_2021_RCDI.subject_A17.2 are the same person, but relative timing is unclear
|
6 |
|
antibiotics administered peri-partum
|
6 |
|
Manually incremented by 1 to avoid same timepoint as T7
|
5 |
|
Subjects Langdon_2021_RCDI.subject_A14.1 and Langdon_2021_RCDI.subject_A14.2 are the same person, but relative timing is unclear
|
5 |
|
Subjects Langdon_2021_RCDI.subject_A18.1 and Langdon_2021_RCDI.subject_A18.2 are the same person, but relative timing is unclear
|
5 |
|
Subjects Langdon_2021_RCDI.subject_A20.1 and Langdon_2021_RCDI.subject_A20.2 are the same person, but relative timing is unclear
|
5 |
|
Subjects Langdon_2021_RCDI.subject_A4.1 and Langdon_2021_RCDI.subject_A4.2 are the same person, but relative timing is unclear
|
5 |
|
Subjects Langdon_2021_RCDI.subject_A8.1 and Langdon_2021_RCDI.subject_A8.2 are the same person, but relative timing is unclear
|
5 |
|
age uncertain
|
5 |
|
Metadata unclear
|
4 |
|
Subjects Langdon_2021_RCDI.subject_A13.1 and Langdon_2021_RCDI.subject_A13.2 are the same person, but relative timing is unclear
|
4 |
|
Subjects Langdon_2021_RCDI.subject_A23.1 and Langdon_2021_RCDI.subject_A23.2 are the same person, but relative timing is unclear
|
4 |
|
Subjects Langdon_2021_RCDI.subject_A28.1 and Langdon_2021_RCDI.subject_A28.2 are the same person, but relative timing is unclear
|
4 |
|
Subjects Langdon_2021_RCDI.subject_A29.1 and Langdon_2021_RCDI.subject_A29.2 are the same person, but relative timing is unclear
|
4 |
|
Subjects Langdon_2021_RCDI.subject_A3.1 and Langdon_2021_RCDI.subject_A3.2 are the same person, but relative timing is unclear
|
4 |
|
Subjects Langdon_2021_RCDI.subject_A5.1 and Langdon_2021_RCDI.subject_A5.2 are the same person, but relative timing is unclear
|
4 |
|
Subjects Langdon_2021_RCDI.subject_A6.1 and Langdon_2021_RCDI.subject_A6.2 are the same person, but relative timing is unclear
|
4 |
|
antibiotics administered prepartum
|
4 |
|
FMT donor was spouse
|
3 |
|
NB: correct donor, but unclear whether sample was used in FMT
|
3 |
|
Subjects Langdon_2021_RCDI.subject_A11.1 and Langdon_2021_RCDI.subject_A11.2 are the same person, but relative timing is unclear
|
3 |
|
Subjects Langdon_2021_RCDI.subject_A2.1 and Langdon_2021_RCDI.subject_A2.2 are the same person, but relative timing is unclear
|
3 |
|
Subjects Langdon_2021_RCDI.subject_A27.1 and Langdon_2021_RCDI.subject_A27.2 are the same person, but relative timing is unclear
|
3 |
|
Subjects Langdon_2021_RCDI.subject_A26.1 and Langdon_2021_RCDI.subject_A26.2 are the same person, but relative timing is unclear
|
2 |
|
Subjects Langdon_2021_RCDI.subject_A33.1 and Langdon_2021_RCDI.subject_A33.2 are the same person, but relative timing is unclear
|
2 |
|
former melanoma patient who has recovered >1 year ago
|
2 |
|
no records on antibiotic treatment
|
2 |
|
A sample Ch36-1 was sequenced, but not used in the original publication
|
1 |
|
A sample Ch41-1 was sequenced, but not used in the original publication
|
1 |
|
BMI according to paper: 0.002156454491374
|
1 |
|
BMI according to paper: 72
|
1 |
|
BMI according to paper: 78.5
|
1 |
|
Male player 1 at home
|
1 |
|
Male player 1 baseline
|
1 |
|
Male player 1 post Australia
|
1 |
|
Male player 1 post India
|
1 |
|
Male player 1 post UAE
|
1 |
|
Male player 1 post Zambia/Namibia
|
1 |
|
Male player 11 at home
|
1 |
|
Male player 11 baseline
|
1 |
|
Male player 11 post Australia
|
1 |
|
Male player 11 post India
|
1 |
|
Male player 11 post UAE
|
1 |
|
Male player 11 post Zambia/Namibia
|
1 |
|
Male player 2 at home
|
1 |
|
Male player 2 baseline
|
1 |
|
Male player 2 post Australia
|
1 |
|
Male player 2 post India
|
1 |
|
Male player 2 post UAE
|
1 |
|
Male player 2 post Zambia/Namibia
|
1 |
|
Male player 3 at home
|
1 |
|
Male player 3 baseline
|
1 |
|
Male player 3 post Australia
|
1 |
|
Male player 3 post India
|
1 |
|
Male player 3 post UAE
|
1 |
|
Male player 3 post Zambia/Namibia
|
1 |
|
Subject also on metronidazole, vancomycin
|
1 |
|
Subject also on metronidazole, vancomycin, probiotic (Cuturelle)
|
1 |
|
Subject also on vancomycin, probiotics
|
1 |
|
antibiotic treatment in the month before sampling
|
1 |
|
antibiotic treatment in the week before sampling
|
1 |
|
treated with Cotrimoxazole two times
|
1 |